Original Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2011; 17(19): 2389-2396
Published online May 21, 2011. doi: 10.3748/wjg.v17.i19.2389
Table 1 Primers and fluorescent probe for human CXC chemokine receptor-4, stromal cell-derived factor-1 and GAPDH
Primers5'-3'Product (bp)
CXCR4Forward: TGGCCTTATCCTGCCTGGTAT173
Reverse: GGAGTCGATGCTGATCCCAAT
Taqman: AGAAGCGCAAGGCCCTCAAGACCA
SDF-1Forward: GAGCCAACGTCAAGCATCTCA103
Reverse: TTCGGGTCAATGCACACTTGT
Taqman: CTGTGCCCTTCAGATTGTAGCCCGG
GAPDHForward: TCATGGGTGTGAACCATGAGAA146
Reverse: GGCATGGACTGTGGTCATGAG
Taqman: TCATCAGCAATGCCTCCTGCACCA
Table 2 Expression of CXC chemokine receptor-4 in primary gastric carcinoma and normal mucous membrane (mean ± SE)
TissuesNo.CXCR4-mRNAtP
Gastric cancer401.6244 ± 1.38012.5540.015
Normal mucous membrane401.0715 ± 0.5243
Table 3 Expression of CXC chemokine receptor-4 in primary gastric carcinoma with or without lymph nodes metastasis (mean ± SE)
Lymph node metastasisNo.CXCR4-mRNAtP
Present320.823 ± 0.5512.1010.042
Absent80.392 ± 0.338
Table 4 Relationship between CXC chemokine receptor-4 expression and clinicopathological features in gastric cancer
Clinicopathologic parametersNo.CXC chemokine receptor-4
PositiveNegativeχ2P value
Sex
Male3118130.0060.9382
Female963
Age (yr)
> 56191270.0070.9351
≤ 5621138
Tumor size (cm)
≥ 5251690.0640.8001
< 51596
Tumor location
Cardia of stomach220-0.8113
Fundus of stomach110
Body of stomach642
Antrum of stomach311813
Differentiation
Moderate/well615-0.0213
Poor342410
Lymph node metastasis
Present322664.1460.0422
Absent835
Stage
II and IIIa238155.0130.0251
IIIb and IV17125
Table 5 Expression of stromal cell-derived factor-1 in lymph nodes with or without gastric cancer cell metastasis (mean ± SE)
Lymph node metastasisNo.SDF-1-mRNAtP
With240.5432 ± 0.49072.3380.025
Without160.2640 ± 0.2601